2569 director jobs found

Supernus Pharmaceuticals wouldn't mind being a drug-maker superhero of sorts to epileptics. As a specialty pharmaceutical company, Supernus develops treatments for epilepsy and other central nervous system disorders.

Supernus Pharmaceuticals wouldn't mind being a drug-maker superhero of sorts to epileptics. As a specialty pharmaceutical company, Supernus develops treatments for epilepsy and other central nervous system disorders.

Supernus Pharmaceuticals wouldn't mind being a drug-maker superhero of sorts to epileptics. As a specialty pharmaceutical company, Supernus develops treatments for epilepsy and other central nervous system disorders.

Supernus Pharmaceuticals wouldn't mind being a drug-maker superhero of sorts to epileptics. As a specialty pharmaceutical company, Supernus develops treatments for epilepsy and other central nervous system disorders.

Supernus Pharmaceuticals wouldn't mind being a drug-maker superhero of sorts to epileptics. As a specialty pharmaceutical company, Supernus develops treatments for epilepsy and other central nervous system disorders.

SMPA is committed to accelerating scientific and therapeutic breakthroughs in key areas of unique and unmet medical need including oncology, urology, women’s health, rare disease, neurology & psychiatry, and cell & gene therapies.

SMPA is committed to accelerating scientific and therapeutic breakthroughs in key areas of unique and unmet medical need including oncology, urology, women’s health, rare disease, neurology & psychiatry, and cell & gene therapies.

SMPA is committed to accelerating scientific and therapeutic breakthroughs in key areas of unique and unmet medical need including oncology, urology, women’s health, rare disease, neurology & psychiatry, and cell & gene therapies.

SMPA is committed to accelerating scientific and therapeutic breakthroughs in key areas of unique and unmet medical need including oncology, urology, women’s health, rare disease, neurology & psychiatry, and cell & gene therapies.

SMPA is committed to accelerating scientific and therapeutic breakthroughs in key areas of unique and unmet medical need including oncology, urology, women’s health, rare disease, neurology & psychiatry, and cell & gene therapies.

SMPA is committed to accelerating scientific and therapeutic breakthroughs in key areas of unique and unmet medical need including oncology, urology, women’s health, rare disease, neurology & psychiatry, and cell & gene therapies.

SMPA is committed to accelerating scientific and therapeutic breakthroughs in key areas of unique and unmet medical need including oncology, urology, women’s health, rare disease, neurology & psychiatry, and cell & gene therapies.

SMPA is committed to accelerating scientific and therapeutic breakthroughs in key areas of unique and unmet medical need including oncology, urology, women’s health, rare disease, neurology & psychiatry, and cell & gene therapies.

SMPA is committed to accelerating scientific and therapeutic breakthroughs in key areas of unique and unmet medical need including oncology, urology, women’s health, rare disease, neurology & psychiatry, and cell & gene therapies.

SMPA is committed to accelerating scientific and therapeutic breakthroughs in key areas of unique and unmet medical need including oncology, urology, women’s health, rare disease, neurology & psychiatry, and cell & gene therapies.

SMPA is committed to accelerating scientific and therapeutic breakthroughs in key areas of unique and unmet medical need including oncology, urology, women’s health, rare disease, neurology & psychiatry, and cell & gene therapies.

SMPA is committed to accelerating scientific and therapeutic breakthroughs in key areas of unique and unmet medical need including oncology, urology, women’s health, rare disease, neurology & psychiatry, and cell & gene therapies.

SMPA is committed to accelerating scientific and therapeutic breakthroughs in key areas of unique and unmet medical need including oncology, urology, women’s health, rare disease, neurology & psychiatry, and cell & gene therapies.

Sun Pharmaceuticals Industries Inc. is the fourth largest generic pharmaceutical company in the world, and rapidly building brand presence in Dermatology, Opthalmics, Oncology, and Long Term Care.

Sun Pharmaceuticals Industries Inc. is the fourth largest generic pharmaceutical company in the world, and rapidly building brand presence in Dermatology, Opthalmics, Oncology, and Long Term Care.